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Pulmonary artery pseudoaneurysm in a patient with Behc¸et disease
Yong Han Yoon, MD,a Kwang Ho Kim, MD,a Wan Ki Baek, MD,a Jung Taek Kim, MD,a Kuk Hee Shon, MD,a
Young Sam Kim, MD,a Hae Seung Han, MD,b and Jae Hwa Cho, MD,c Incheon, Korea
Behc¸et disease is a rare and chronic disorder of unknowncause characterized by the inflammation of blood ves-sels; pulmonary involvement occurs in only about 1%to 7% of patients.1-4 Of the pulmonary manifestations,
the pulmonary arteries are second to the aorta as the most common
site of arterial involvement. Pulmonary artery aneurysm, in par-
ticular, has a poor prognosis and is one of the leading causes of
death in patients with Behc¸et disease. Mean survival after the onset
of hemoptysis was reported to be about 10 months in one study of
patients with Behc¸et disease and pulmonary artery aneurysm.5 We
report a case involving a young female patient who presented with
a variety of symptoms, leading to a diagnosis of Behc¸et disease
and treatment for pulmonary artery pseudoaneurysm after appro-
priate investigations and surgical intervention. After a right lower
lobe lobectomy, no further hemoptysis and skin lesions have
occurred 20 months postoperatively.
Clinical Summary
A 35-year-old woman was admitted to Inha University Hospital,
Incheon, Korea, because of high fever and cough for the previous
2 months. For the previous 3 years, she had recurrent episodes of
oral ulceration. A chest radiograph taken 2 months before admis-
sion showed a mass-like lesion in the right lower lung field.
Physical examination revealed several small, ulcerated lesions on
her external genitalia. However, her breath sounds were clean, and
heart sounds were regular and without murmur. Pathergy test
results were positive, but the results of other blood tests were
within normal limits. The chest radiograph showed a round mass
6  7 cm in diameter in the right lower lung field (Figure 1). The
computed tomographic scan of the chest, enhanced through intra-
venous injection of contrast media, showed that the mass origi-
nated from the right lower pulmonary artery. Behc¸et disease with
pulmonary artery aneurysm was investigated on the basis of the
aforementioned findings.
Seven days after admission, the patient had a high fever with
sudden hemoptysis of about 30 mL. The follow-up chest radio-
graph showed the lung mass had increased in size since admission.
A magnetic resonance imaging study confirmed a ruptured aneu-
rysm of the right lower lobar pulmonary artery, indicating a
pulmonary artery pseudoaneurysm (Figure 2). A lobectomy of the
right lower lobe was performed, and a cystic mass containing
blood and measuring 4  4  4 cm in size was found in the
superior segment of the lobe. The patient’s postoperative course
was uneventful. The pathologic findings revealed that the cystic
lesion was a ruptured aneurysm of the large pulmonary artery.
Elastic staining of this involved pulmonary artery showed that a
portion of the wall was destroyed and replaced by inflamed fibrous
tissue. The cellular infiltrate of the vessel wall was found to be
predominantly composed of lymphocytes, macrophages, neutro-
phils, and eosinophils. Periadventitial fibrosis was predominant,
and an organized thrombus with recanalization of a branch of the
pulmonary artery was also found. Vasculitis in this case involved
the large pulmonary artery only because vessels of different types
and sizes were not affected. A pulmonary artery bronchial fistula
formed because of the spread of inflammation and necrosis from
the fibrous wall of an elastic pulmonary artery aneurysm into an
adjacent bronchus (Figure 3). Seven days postoperatively, the
chest tube was removed. During the postoperative course, skin
lesions developed as a result of trauma, such as venipuncture and
arterial puncture. The patient was administered a course of corti-
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Figure 1. The posteroanterior chest radiograph showed a round
mass 6  7 cm in diameter in the right lower lung fields.
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costeroids, and no further hemoptysis and skin lesions occurred in
the 20 months after the lobectomy.
Discussion
The vascular system is affected in 25% of patients with Behc¸et
disease, with specifically pulmonary manifestations occurring in
between only 1% and 7% of patients.1 Pulmonary artery aneu-
rysms, in particular, have a poor prognosis and are one of the
leading causes of patient death in Behc¸et disease. Unfortunately,
no prospective studies have examined the true prevalence of the
pulmonary manifestations of the disease. Aneurysms of pulmonary
arteries are very rare. Aortic manifestations are the most common
vascular involvement, and pseudoaneurysms in this area have been
reported.6,7 Pulmonary artery pseudoaneurysms have not been
reported in the literature until our case study. Generally, pulmo-
nary artery pseudoaneurysms occur as a result of erosion of the
artery by mycotic aneurysms derived from right-side bacterial
endocarditis or infected thrombi from peripheral veins; trauma and
chronic pulmonary hypertension, particularly that associated with
congenital heart disease, in which a left-to-right shunt develops;
and septic emboli. Behc¸et disease should be included in the listing
of diseases causing aneurysms of the large pulmonary arteries.
Important complications of pulmonary angitis in Behc¸et disease
include vascular thromboses, pulmonary infarction, bronchial ero-
sion by pulmonary arteries, and pulmonary artery aneurysm.1,2,8
Pulmonary vasculitis in Behc¸et disease is a unique clinical and
pathologic picture.1-4,8 Pulmonary artery aneurysms are located
mainly in the right lower lobar arteries, followed by the right and
left main pulmonary arteries.8 The pulmonary manifestations ap-
pear, on average, 3.6 years after the first extrapulmonary manifes-
tation. Hemoptysis is the major pulmonary manifestation and is
reported to occur in 77% of reported cases. Hemoptysis might
result from the acute inflammatory destruction of elastic and
muscular pulmonary arteries, the rupture of pulmonary artery
aneurysms, pulmonary infarcts, erosion of pulmonary artery aneu-
rysm into adjacent bronchi, and finally, the extensive inflammatory
disruption of alveolar capillaries.1-5,8 In our case hemoptysis re-
sulted from the erosion of the pulmonary artery pseudoaneurysm
into adjacent bronchi. One characteristic of Behc¸et disease is that
vasculitis can occur in different types of pulmonary vessels and
might involve large and small vessels simultaneously or separately
in the course of the disease.
Chest x-ray films showed abnormal findings in 90% of the
cases. Helical computed tomography is currently the method of
choice for confirming the diagnosis because it provides an
excellent vascular image, requiring only a small quantity of
contrast material. Magnetic resonance imaging is also helpful in
the diagnosis of pulmonary artery aneurysms and pseudoaneu-
rysms.
Currently, the mainstay of treatment is immunosuppressants,
especially when introduced in the early stages before irreversible
damage to the arterial wall develops. Anticoagulant therapy holds
potential hazards to patients with aneurysmal dilatation of the
pulmonary blood vessels. When the disease is localized to one area
of the lung, surgical excision, followed by medical treatment, is
indicated to prevent fatal pulmonary hemorrhage.
In patients with massive hemoptysis, urgent surgical resection
might be necessary and after postoperative steroid treatment be-
cause perioperative steroid therapy has been suggested to reduce
the risk of complications.
In our patient no further hemoptysis occurred 20 months after
the lobectomy.
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Methylene blue for lithium-induced refractory hypotension in off-pump
coronary artery bypass graft: Report of two cases
Donatella Sparicio, MD, Giovanni Landoni, MD, Federico Pappalardo, MD, Martina Crivellari, MD, Elisa Cerchierini, MD,
Giovanni Marino, MD, and Alberto Zangrillo, MD, Milano, Italy
Off-pump surgery is gaining popularity for coronaryartery bypass grafting (CABG). We report the peri-operative management of 2 patients who self-assumedlithium and had refractory hypotension during beating
heart surgery. Both patients had a dramatic hemodynamic im-
provement after receiving methylene blue.
Clinical Summary
Two men (57 and 68 years, each weighing 72 kg, height 180 and
186 cm) with coronary artery disease and ejection fraction greater
than 50% were scheduled for elective off-pump CABG. Medical
history included depression on treatment with benzodiazepines and
lithium carbonate (300 mg every 8 hours). They were both on
treatment with beta-blockers (atenolol and carvedilol), calcium
antagonist (amlodipine), nitrates, and aspirin; patient A also used
an angiotensin-converting enzyme inhibitor. Both patients had an
unnoticed self-administration of lithium the morning before sur-
gery.
Standard premedication and anesthesia were administered. Tar-
get coronary vessels were mechanically stabilized and posterior
vessel presentation obtained with a suspension stitch placed in the
middle of the 4 pulmonary veins. Both patients received an in situ
internal thoracic artery graft to the left anterior descending artery
and a saphenous vein graft to the posterior descending and obtuse
marginal arteries. Hypotension ensued after pericardial opening
and anastomosis. Arterial blood pressure, 80/50 mm Hg (mean
arterial pressure  60 mm Hg), was not responsive to etilephrine
boluses, atrial pacing, dopamine infusion (10 g/kg/min), steep
Trendelenburg position, fluid loading, and opening of both pleura;
nevertheless, patients’ stability, in the absence of arrhythmias or
ST-T changes, maintenance of diuresis, and an optimal coopera-
tion between anesthesiologist and surgeon, permitted concluding
the procedure without converting to cardiopulmonary bypass. In-
traoperative transesophageal echocardiography demonstrated nor-
mal biventricular function without new segmental acinesia. In the
hypothesis of vasoplegia both patients received methylene blue
(1.5 mg/kg intravenously) in 20 minutes with a rapid improvement
of mean arterial pressure (80 mm Hg).
At the end of the operation, the patients were transferred to the
intensive care unit and had an uneventful postoperative course.
Discussion
Lithium (Li), the primary drug used for the treatment of bipolar
(maniac-depressive) disorders, may induce prolonged sleep time
after barbiturate anesthesia, enhanced neuromuscular blockade
after muscle relaxant administration, and cardiac conduction ab-
normalities.1 The mechanism of action of Li as a mood-stabiliz-
ing agent remains unknown. Therapeutic doses of lithium interfere
with the metabolism of cathecolamines that are involved in the
pathophysiology of the troubles of humor; Li also inhibits the
liberation of norepinephrine and dopamine from the nervous ter-
minations, strengthens the liberation of serotonin, and increases
the presynaptic reuptake and storage of catecholamines. Further-
more, it has interactions with drugs like angiotensin-converting
enzyme inhibitors (which reduce Li clearance with possible Li
toxicity) and beta-blockers (which enhance the central depression
induced by lithium).
In light of these pharmacodynamic properties, in these patients
we suspected that chronic lithium therapy played a role in the
unresponsiveness to vasoconstrictor agents. Lithium should be
discontinued before surgery, at least the day of the operation,
especially when high blood pressures are requested during sur-
gery.2
Methylene blue inhibits the enzyme guanylate cyclase, avoid-
ing the cyclic guanosine 3'5'-monophosphate-dependent vasore-
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